NeuroOne Medical Technologies Corporation - Common Stock (NMTC)
0.6440
+0.00 (0.00%)
NASDAQ · Last Trade: May 14th, 9:25 AM EDT
Detailed Quote
Previous Close
0.6440
Open
-
Bid
0.6300
Ask
0.6500
Day's Range
N/A - N/A
52 Week Range
0.3954 - 1.390
Volume
1,153
Market Cap
7.73M
PE Ratio (TTM)
-2.927
EPS (TTM)
-0.2
Dividend & Yield
N/A (N/A)
1 Month Average Volume
413,970
Chart
About NeuroOne Medical Technologies Corporation - Common Stock (NMTC)
Neuroone Medical Technologies Corp is a pioneering medical technology company focused on developing innovative solutions for neurological disorders. The company specializes in creating advanced devices and technologies aimed at improving the diagnosis and treatment of conditions such as epilepsy, Parkinson's disease, and chronic pain. Neuroone's offerings include breakthrough electrode systems that facilitate precise brain interaction, enabling better therapeutic outcomes. Through their commitment to research and development, Neuroone seeks to address critical healthcare needs in the neurology field while enhancing patients' quality of life. Read More
NeuroOne submits FDA filing early for trigeminal nerve ablation using its OneRF system as the facial pain market sees projected growth to $416 million by 2030.
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.
NEW YORK, NY / ACCESSWIRE / December 3, 2024 / Investor Summit Group, committed to advancing the MicroCap and SmallCap investment community, announces that the November 21, 2024 Winter Investor Summit Virtual Conference presentations are now available for on-demand viewing.
EDEN PRAIRIE, MN / ACCESSWIRE / November 13, 2024 / NeuroOne Medical Technologies Corporation (Nasdaq:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it will be participating in the Virtual Investor Summit Microcap Event. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation.
NMTC stock results show that NeuroOne Medical Tech missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
